Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Intel Trader who wrote (4427)	6/3/1998 9:20:00 PM
From: tommysdad	Read Replies (1) of 6136

<<impending FDA approval over a year hence>> That's kind of stretching it. What they are saying is that they expect to file an NDA sometime in 2000. Final approval could take up to a year after that. And that assumes the PIII trials go exceptionally well. Kind of hard to predict since I have not seen any results from the PII trials. I must say I have been fairly disappointed with AGPH's PR efforts of late. They used to be the "under promise over deliver" company. Recently, in light of the ENMD fiasco, they put out a "hey, look at us, we're kind of working on angiogenesis too" press release, and now we see a press release anticipating an NDA filing 18 months hence, with no PIII data on which to base such an estimate. What gives here? Are we sensing panic? Hey, I believe AGPH to be relatively undervalued at these levels. Just divide market cap by sales and it's ridiculous. But what is spurring AGPH to put out the kind of press releases people on this board used to make fun of? Are they sensing a takeover bid in the wings and trying to boost the stock price to prevent such a disaster?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next